Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
AI team at Insilico gets some major league backing from China as Alex Zhavoronkov builds global network
8 years ago
Financing
China
After cash funneling scandal, biotech billionaire Soon-Shiong charges on with Nant IPO
8 years ago
People
Financing
Bitterly opposed old guard at Takeda wages a last-ditch fight to block 'foreign blood's' $62B Shire buyout
8 years ago
Deals
Alexion cautiously steps over to the C6 pathway with an early-stage development deal tied to buyout option
8 years ago
Pharma
Sanofi builds on mRNA alliances with an $805M pact for Ron Renaud’s Translate Bio
8 years ago
R&D
Pharma
AbbVie, Roche post a big win with a blockbuster FDA OK for Venclexta/Rituxan combo for leukemia
8 years ago
Pharma
Strike two: Vical says another one of its vaccines has crashed and burned in PhII
8 years ago
R&D
Visualize: ASCO 2018's winners and losers
8 years ago
R&D
Pharma
Rubius snaps up Novartis vet Pablo Cagnoni as CEO; MiMedx dumps two execs following internal investigation
8 years ago
Peer Review
Alnylam's updated lumasiran data points to PhIII short track; Genentech snatches fourth approval for Rituxan
8 years ago
News Briefing
After snatching up Shire's cancer unit, French pharma giant Servier to expand US presence with Kendall Square ...
8 years ago
R&D
Ex-con Sam Waksal's startup prices IPO, joining parade of biotechs with Nasdaq news
8 years ago
Financing
Sound familiar? China/US biotech hybrid lands rights to cancer drugs, cash and a team of development vets to launch ...
8 years ago
Financing
Startups
Diabetes giant Novo said to consider up to 3,000 layoffs as US pricing storms gather: report
8 years ago
R&D
Pharma
Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs
8 years ago
R&D
Pharma
Gates Foundation sets up biotech-like institute in hands-on effort to spur drug development for neglected diseases
8 years ago
R&D
Pharma
Proteostasis shares whacked hard as CF drug falls short; Advaxis axes trial plans in wake of a clinical hold
8 years ago
News Briefing
On an executive hiring spree, Sarepta snags Biogen's Gilmore O'Neill as new CMO
8 years ago
People
That big Biogen deal you were waiting for? Keep waiting
8 years ago
Pharma
Mega-blockbuster? Pfizer lines up for a snap review of its PARP drug talazoparib — and a launch into a crowded ...
8 years ago
Pharma
Notorious activist investor Carl Icahn buys small stake in Allergan
8 years ago
People
Tilting at vaccines giants, SutroVax fuels up on a $170M-plus quest to vault past the world's best-selling vaccine
8 years ago
Financing
Manufacturing experts at Hangzhou Just Biotherapeutics bank $35M for stealthy R&D in China and the US
8 years ago
Financing
China
Biogen, Eisai BACE drug cuts amyloid beta in the brain, but there’s no hard data to show it does anything important ...
8 years ago
R&D
First page
Previous page
1037
1038
1039
1040
1041
1042
1043
Next page
Last page